Search

Your search keyword '"Chin, Joseph L."' showing total 789 results
Start Over Author "Chin, Joseph L."
789 results on '"Chin, Joseph L."'

1. Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement

Author

Deivasigamani, Sriram, Kotamarti, Srinath, Rastinehad, Ardeshir R., Salas, Rafael Sanchez, de la Rosette, J.J.M.C.H., Lepor, Herbert, Pinto, Peter, Ahmed, Hashim U., Gill, Inderbir, Klotz, Laurence, Taneja, Samir S., Emberton, Mark, Lawrentschuk, Nathan, Wysock, James, Feller, John F., Crouzet, Sebastien, Kumar M., Praveen, Seguier, Denis, Adams, Eric S., Michael, Zoe, Abreu, Andre, Jack Tay, Kae, Ward, John F., Shinohara, Katsuto, Katz, Aaron E., Villers, Arnauld, Chin, Joseph L., Stricker, Phillip D., Baco, Eduard, Macek, Petr, Ahmad, Ardalan E., Chiu, Peter K.F., Crawford, E. David, Rogers, Craig G., Futterer, Jurgen J., Rais-Bahrami, Soroush, Robertson, Cary N., Hadaschik, Boris, Marra, Giancarlo, Valerio, Massimo, Chong, Kian Tai, Kasivisvanathan, Veeru, Tan, Wei Phin, Lomas, Derek, Walz, Jochen, Guimaraes, Gustavo Cardoso, Mertziotis, Nikos I., Becher, Ezequiel, Finelli, Antonio, Kasraeian, Ali, Lebastchi, Amir H., Vora, Anup, Rosen, Mark A., Bakir, Baris, Arcot, Rohit, Yee, Samuel, Netsch, Christopher, Meng, Xiaosong, de Reijke, Theo M., Tan, Yu Guang, Regusci, Stefano, Benjamin, Tavya G.R., Olivares, Ruben, Noureldin, Mohamed, Bianco, Fernando J., Sivaraman, Arjun, Kim, Fernando J., Given, Robert W., Dason, Shawn, Sheetz, Tyler J., Shoji, Sunao, Schulman, Ariel, Royce, Peter, Shah, Taimur T., Scionti, Stephen, Salomon, Georg, Laguna, Pilar, Tourinho-Barbosa, Rafael, Aminsharifi, Alireza, Cathelineau, Xavier, Gontero, Paolo, Stabile, Armando, Grummet, Jeremy, Ledbetter, Leila, Graton, Margaret, Stephen Jones, J., and Polascik, Thomas J.

Published
2023
Full Text
View/download PDF

2. The Burden of Uncontrolled Cardiovascular Risk Factors in Men With Prostate Cancer: A RADICAL-PC Analysis

Author

Klimis, Harry, Pinthus, Jehonathan H., Aghel, Nazanin, Duceppe, Emmanuelle, Fradet, Vincent, Brown, Ian, Siemens, D. Robert, Shayegan, Bobby, Klotz, Laurence, Luke, Patrick P., Niazi, Tamim, Lavallee, Luke T., Mousavi, Negareh, Hamilton, Robert J., Chin, Joseph L., Gopaul, Darin, Violette, Philippe D., Davis, Margot K., Hanna, Nawar, Sabbagh, Robert, Ben Zadok, Osnat Itzhaki, Hajjar, Ludhmila Abrahão, Kann, Ariel Galapo, Mian, Rajibul, Rangarajan, Sumathy, Huei Ng, Kelvin Kuan, Iakobishvili, Zaza, Selvanayagam, Joseph B., Avezum, Alvaro, and Leong, Darryl P.

Published
2023
Full Text
View/download PDF

5. Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials

Author

Kwak, Lucia, primary, Ravi, Praful, additional, Armstrong, John G., additional, Beckendorf, Veronique, additional, Chin, Joseph L., additional, D'Amico, Anthony V., additional, Dearnaley, David P., additional, Di Stasi, Savino M., additional, Gillessen, Silke, additional, Lukka, Himanshu, additional, Mottet, Nicolas, additional, Pommier, Pascal, additional, Seiferheld, Wendy, additional, Sydes, Matthew R., additional, Tombal, Bertrand, additional, Zapatero, Almudena, additional, Regan, Meredith M., additional, Xie, Wanling, additional, and Sweeney, Christopher J., additional

Published
2024
Full Text
View/download PDF

8. Genetic testing practices among specialist physicians who treat prostate cancer

Author

Yip, Steven M., primary, Morash, Christopher, additional, Kolinsky, Michael P., additional, Kapoor, Anil, additional, Ong, Michael, additional, Selvarajah, Shamini, additional, Nuk, Jennifer, additional, Compton, Katie, additional, Pouliot, Frederic, additional, Lavallée, Luke T., additional, Khalaf, Daniel J., additional, Hamilton, Robert J., additional, Gotto, Geoffrey T., additional, Rendon, Ricardo A., additional, Antebi, Elie, additional, Hotte, Sebastien J., additional, Malone, Shawn, additional, Chi, Kim N., additional, Drachenberg, Darrel E., additional, Saad, Fred, additional, Chan, Jonathan, additional, Ferrario, Cristiano, additional, Ko, Jenny, additional, Shayegan, Bobby, additional, Parimi, Sunil, additional, So, Alan I., additional, Feifer, Andrew, additional, Jansz, Kenneth, additional, Finch, Daygen, additional, Chin, Joseph L., additional, Osborne, Brendan, additional, Ho, Kai Fai, additional, Demanga Galamo, Corine, additional, Zardan, Anousheh, additional, and Niazi, Tamim, additional

Published
2023
Full Text
View/download PDF

9. Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Author

Klein, Eric A, Thompson, Ian M, Tangen, Catherine M, Crowley, John J, Lucia, M Scott, Goodman, Phyllis J, Minasian, Lori M, Ford, Leslie G, Parnes, Howard L, Gaziano, J Michael, Karp, Daniel D, Lieber, Michael M, Walther, Philip J, Klotz, Laurence, Parsons, J Kellogg, Chin, Joseph L, Darke, Amy K, Lippman, Scott M, Goodman, Gary E, Meyskens, Frank L, and Baker, Laurence H

Subjects
Clinical Research, Aging, Nutrition, Complementary and Integrative Health, Cancer, Clinical Trials and Supportive Activities, Urologic Diseases, Prostate Cancer, Prevention, 3.3 Nutrition and chemoprevention, Evaluation of treatments and therapeutic interventions, Prevention of disease and conditions, and promotion of well-being, 6.1 Pharmaceuticals, Aged, Antioxidants, Dietary Supplements, Follow-Up Studies, Humans, Incidence, Male, Middle Aged, Prostatic Neoplasms, Risk, Selenium, Vitamin E, Medical and Health Sciences, General & Internal Medicine
Abstract

ContextThe initial report of the Selenium and Vitamin E Cancer Prevention Trial (SELECT) found no reduction in risk of prostate cancer with either selenium or vitamin E supplements but a statistically nonsignificant increase in prostate cancer risk with vitamin E. Longer follow-up and more prostate cancer events provide further insight into the relationship of vitamin E and prostate cancer.ObjectiveTo determine the long-term effect of vitamin E and selenium on risk of prostate cancer in relatively healthy men.Design, setting, and participantsA total of 35,533 men from 427 study sites in the United States, Canada, and Puerto Rico were randomized between August 22, 2001, and June 24, 2004. Eligibility criteria included a prostate-specific antigen (PSA) of 4.0 ng/mL or less, a digital rectal examination not suspicious for prostate cancer, and age 50 years or older for black men and 55 years or older for all others. The primary analysis included 34,887 men who were randomly assigned to 1 of 4 treatment groups: 8752 to receive selenium; 8737, vitamin E; 8702, both agents, and 8696, placebo. Analysis reflect the final data collected by the study sites on their participants through July 5, 2011.InterventionsOral selenium (200 μg/d from L-selenomethionine) with matched vitamin E placebo, vitamin E (400 IU/d of all rac-α-tocopheryl acetate) with matched selenium placebo, both agents, or both matched placebos for a planned follow-up of a minimum of 7 and maximum of 12 years.Main outcome measuresProstate cancer incidence.ResultsThis report includes 54,464 additional person-years of follow-up and 521 additional cases of prostate cancer since the primary report. Compared with the placebo (referent group) in which 529 men developed prostate cancer, 620 men in the vitamin E group developed prostate cancer (hazard ratio [HR], 1.17; 99% CI, 1.004-1.36, P = .008); as did 575 in the selenium group (HR, 1.09; 99% CI, 0.93-1.27; P = .18), and 555 in the selenium plus vitamin E group (HR, 1.05; 99% CI, 0.89-1.22, P = .46). Compared with placebo, the absolute increase in risk of prostate cancer per 1000 person-years was 1.6 for vitamin E, 0.8 for selenium, and 0.4 for the combination.ConclusionDietary supplementation with vitamin E significantly increased the risk of prostate cancer among healthy men.Trial registrationClinicaltrials.gov Identifier: NCT00006392.

Published
2011

11. A Canadian center's experience on whole-gland salvage therapy for radio-recurrent prostate cancer with various modalities.

Author

Chin, Joseph L., Cendejas-Gomez, J. Jesus, and Peters, Max

Subjects
*DIGITAL image processing, *PROSTATECTOMY, *ULTRASONIC imaging, *CANCER relapse, *CRYOSURGERY, *CONTINUING education units, *MICROWAVES, *TREATMENT effectiveness, *DIAGNOSTIC imaging, *ELECTROPORATION, *SALVAGE therapy, *PROGRESSION-free survival, *PROSTATE tumors, *OVERALL survival, *ABLATION techniques, *EVALUATION
Abstract

The article focuses on a quarter-century review of whole-gland salvage ablation therapies for radio-recurrent prostate cancer at Western University, emphasizing cryoablation, high-intensity focused ultrasound (HIFU), and interstitial laser photodynamic therapy (PDT). Topics discussed include long-term outcomes, complications, comparisons with salvage prostatectomy, and the potential role of next-generation functional imaging for prostate cancer and salvage ablation.

Published
2023
Full Text
View/download PDF

12. Supplementary Figure Legends 1-6 from Functional Neoangiogenesis Imaging of Genetically Engineered Mouse Prostate Cancer Using Three-Dimensional Power Doppler Ultrasound

Author

Xuan, Jim W., primary, Bygrave, Michael, primary, Jiang, Hongyi, primary, Valiyeva, Fatma, primary, Dunmore-Buyze, Joy, primary, Holdsworth, David W., primary, Izawa, Jonathan I., primary, Bauman, Glenn, primary, Moussa, Madeleine, primary, Winter, Scott F., primary, Greenberg, Norman M., primary, Chin, Joseph L., primary, Drangova, Maria, primary, Fenster, Aaron, primary, and Lacefield, James C., primary

Published
2023
Full Text
View/download PDF

13. Supplementary Movie 1 from Functional Neoangiogenesis Imaging of Genetically Engineered Mouse Prostate Cancer Using Three-Dimensional Power Doppler Ultrasound

Author

Xuan, Jim W., primary, Bygrave, Michael, primary, Jiang, Hongyi, primary, Valiyeva, Fatma, primary, Dunmore-Buyze, Joy, primary, Holdsworth, David W., primary, Izawa, Jonathan I., primary, Bauman, Glenn, primary, Moussa, Madeleine, primary, Winter, Scott F., primary, Greenberg, Norman M., primary, Chin, Joseph L., primary, Drangova, Maria, primary, Fenster, Aaron, primary, and Lacefield, James C., primary

Published
2023
Full Text
View/download PDF

14. Supplementary Figure 2 from Functional Neoangiogenesis Imaging of Genetically Engineered Mouse Prostate Cancer Using Three-Dimensional Power Doppler Ultrasound

Author

Xuan, Jim W., primary, Bygrave, Michael, primary, Jiang, Hongyi, primary, Valiyeva, Fatma, primary, Dunmore-Buyze, Joy, primary, Holdsworth, David W., primary, Izawa, Jonathan I., primary, Bauman, Glenn, primary, Moussa, Madeleine, primary, Winter, Scott F., primary, Greenberg, Norman M., primary, Chin, Joseph L., primary, Drangova, Maria, primary, Fenster, Aaron, primary, and Lacefield, James C., primary

Published
2023
Full Text
View/download PDF

15. Supplementary Movie 1 from Integrin-Free Tetraspanin CD151 Can Inhibit Tumor Cell Motility upon Clustering and Is a Clinical Indicator of Prostate Cancer Progression

Author

Palmer, Trenis D., primary, Martínez, Carlos H., primary, Vasquez, Catalina, primary, Hebron, Katie E., primary, Jones-Paris, Celestial, primary, Arnold, Shanna A., primary, Chan, Susanne M., primary, Chalasani, Venu, primary, Gomez-Lemus, Jose A., primary, Williams, Andrew K., primary, Chin, Joseph L., primary, Giannico, Giovanna A., primary, Ketova, Tatiana, primary, Lewis, John D., primary, and Zijlstra, Andries, primary

Published
2023
Full Text
View/download PDF

16. Data from Integrin-Free Tetraspanin CD151 Can Inhibit Tumor Cell Motility upon Clustering and Is a Clinical Indicator of Prostate Cancer Progression

Author

Palmer, Trenis D., primary, Martínez, Carlos H., primary, Vasquez, Catalina, primary, Hebron, Katie E., primary, Jones-Paris, Celestial, primary, Arnold, Shanna A., primary, Chan, Susanne M., primary, Chalasani, Venu, primary, Gomez-Lemus, Jose A., primary, Williams, Andrew K., primary, Chin, Joseph L., primary, Giannico, Giovanna A., primary, Ketova, Tatiana, primary, Lewis, John D., primary, and Zijlstra, Andries, primary

Published
2023
Full Text
View/download PDF

17. Supplementary Figure 3 from Functional Neoangiogenesis Imaging of Genetically Engineered Mouse Prostate Cancer Using Three-Dimensional Power Doppler Ultrasound

Author

Xuan, Jim W., primary, Bygrave, Michael, primary, Jiang, Hongyi, primary, Valiyeva, Fatma, primary, Dunmore-Buyze, Joy, primary, Holdsworth, David W., primary, Izawa, Jonathan I., primary, Bauman, Glenn, primary, Moussa, Madeleine, primary, Winter, Scott F., primary, Greenberg, Norman M., primary, Chin, Joseph L., primary, Drangova, Maria, primary, Fenster, Aaron, primary, and Lacefield, James C., primary

Published
2023
Full Text
View/download PDF

18. Supplementary Figure 4 from Functional Neoangiogenesis Imaging of Genetically Engineered Mouse Prostate Cancer Using Three-Dimensional Power Doppler Ultrasound

Author

Xuan, Jim W., primary, Bygrave, Michael, primary, Jiang, Hongyi, primary, Valiyeva, Fatma, primary, Dunmore-Buyze, Joy, primary, Holdsworth, David W., primary, Izawa, Jonathan I., primary, Bauman, Glenn, primary, Moussa, Madeleine, primary, Winter, Scott F., primary, Greenberg, Norman M., primary, Chin, Joseph L., primary, Drangova, Maria, primary, Fenster, Aaron, primary, and Lacefield, James C., primary

Published
2023
Full Text
View/download PDF

19. Supplementary Procedures from Functional Neoangiogenesis Imaging of Genetically Engineered Mouse Prostate Cancer Using Three-Dimensional Power Doppler Ultrasound

Author

Xuan, Jim W., primary, Bygrave, Michael, primary, Jiang, Hongyi, primary, Valiyeva, Fatma, primary, Dunmore-Buyze, Joy, primary, Holdsworth, David W., primary, Izawa, Jonathan I., primary, Bauman, Glenn, primary, Moussa, Madeleine, primary, Winter, Scott F., primary, Greenberg, Norman M., primary, Chin, Joseph L., primary, Drangova, Maria, primary, Fenster, Aaron, primary, and Lacefield, James C., primary

Published
2023
Full Text
View/download PDF

20. Supplementary Tables 1 through 3 from Integrin-Free Tetraspanin CD151 Can Inhibit Tumor Cell Motility upon Clustering and Is a Clinical Indicator of Prostate Cancer Progression

Author

Palmer, Trenis D., primary, Martínez, Carlos H., primary, Vasquez, Catalina, primary, Hebron, Katie E., primary, Jones-Paris, Celestial, primary, Arnold, Shanna A., primary, Chan, Susanne M., primary, Chalasani, Venu, primary, Gomez-Lemus, Jose A., primary, Williams, Andrew K., primary, Chin, Joseph L., primary, Giannico, Giovanna A., primary, Ketova, Tatiana, primary, Lewis, John D., primary, and Zijlstra, Andries, primary

Published
2023
Full Text
View/download PDF

21. Supplementary Figure 5 from Functional Neoangiogenesis Imaging of Genetically Engineered Mouse Prostate Cancer Using Three-Dimensional Power Doppler Ultrasound

Author

Xuan, Jim W., primary, Bygrave, Michael, primary, Jiang, Hongyi, primary, Valiyeva, Fatma, primary, Dunmore-Buyze, Joy, primary, Holdsworth, David W., primary, Izawa, Jonathan I., primary, Bauman, Glenn, primary, Moussa, Madeleine, primary, Winter, Scott F., primary, Greenberg, Norman M., primary, Chin, Joseph L., primary, Drangova, Maria, primary, Fenster, Aaron, primary, and Lacefield, James C., primary

Published
2023
Full Text
View/download PDF

22. Supplementary Figure and Movie Legend from Integrin-Free Tetraspanin CD151 Can Inhibit Tumor Cell Motility upon Clustering and Is a Clinical Indicator of Prostate Cancer Progression

Author

Palmer, Trenis D., primary, Martínez, Carlos H., primary, Vasquez, Catalina, primary, Hebron, Katie E., primary, Jones-Paris, Celestial, primary, Arnold, Shanna A., primary, Chan, Susanne M., primary, Chalasani, Venu, primary, Gomez-Lemus, Jose A., primary, Williams, Andrew K., primary, Chin, Joseph L., primary, Giannico, Giovanna A., primary, Ketova, Tatiana, primary, Lewis, John D., primary, and Zijlstra, Andries, primary

Published
2023
Full Text
View/download PDF

23. Supplementary Figure 6 from Functional Neoangiogenesis Imaging of Genetically Engineered Mouse Prostate Cancer Using Three-Dimensional Power Doppler Ultrasound

Author

Xuan, Jim W., primary, Bygrave, Michael, primary, Jiang, Hongyi, primary, Valiyeva, Fatma, primary, Dunmore-Buyze, Joy, primary, Holdsworth, David W., primary, Izawa, Jonathan I., primary, Bauman, Glenn, primary, Moussa, Madeleine, primary, Winter, Scott F., primary, Greenberg, Norman M., primary, Chin, Joseph L., primary, Drangova, Maria, primary, Fenster, Aaron, primary, and Lacefield, James C., primary

Published
2023
Full Text
View/download PDF

25. Validation of Direct Registration of Whole-Mount Prostate Digital Histopathology to ex vivo MR Images

Author

Gibson, Eli, Crukley, Cathie, Gomez, José, Moussa, Madeleine, Chin, Joseph L., Bauman, Glenn, Fenster, Aaron, Ward, Aaron D., Hutchison, David, Series editor, Kanade, Takeo, Series editor, Kittler, Josef, Series editor, Kleinberg, Jon M., Series editor, Mattern, Friedemann, Series editor, Mitchell, John C., Series editor, Naor, Moni, Series editor, Nierstrasz, Oscar, Series editor, Pandu Rangan, C., Series editor, Steffen, Bernhard, Series editor, Sudan, Madhu, Series editor, Terzopoulos, Demetri, Series editor, Tygar, Doug, Series editor, Vardi, Moshe Y., Series editor, Weikum, Gerhard, Series editor, Madabhushi, Anant, editor, Dowling, Jason, editor, Huisman, Henkjan, editor, and Barratt, Dean, editor

Published
2011
Full Text
View/download PDF

27. Effect of body mass index on the outcomes of patients with upper and lower urinary tract cancers treated by radical surgery: Results from a Canadian multicenter collaboration

Author

Bachir, Bassel G., Aprikian, Armen G., Izawa, Jonathan I., Chin, Joseph L., Fradet, Yves, Fairey, Adrian, Estey, Eric, Jacobsen, Niels, Rendon, Ricardo, Cagiannos, Ilias, Lacombe, Louis, Lattouf, Jean-Baptiste, Kapoor, Anil, Matsumoto, Edward, Saad, Fred, Bell, David, Black, Peter C., So, Alan I., Drachenberg, Darrel, and Kassouf, Wassim

Published
2014
Full Text
View/download PDF

32. Long-Term Outcomes of Whole Gland Salvage Cryotherapy for Locally Recurrent Prostate Cancer following Radiation Therapy: A Combined Analysis of Two Centers

Author

Chin, Joseph L., primary, Lavi, Arnon, additional, Metcalfe, Michael J., additional, Siddiqui, Khuram, additional, Dewar, Malcolm, additional, Petros, Firas G., additional, Li, Roger, additional, Nogueras González, Graciela M., additional, Wang, Xuemei, additional, Nair, Shiva M., additional, Ward, John F., additional, and Pisters, Louis, additional

Published
2021
Full Text
View/download PDF

37. Magnetic resonance imaging‐guided transurethral ultrasound ablation in patients with localised prostate cancer: 3‐year outcomes of a prospective Phase I study

Author

Nair, Shiva M., primary, Hatiboglu, Gencay, additional, Relle, James, additional, Hetou, Khalil, additional, Hafron, Jason, additional, Harle, Christopher, additional, Kassam, Zahra, additional, Staruch, Robert, additional, Burtnyk, Mathieu, additional, Bonekamp, David, additional, Schlemmer, Heinz‐Peter, additional, Roethke, Matthias C., additional, Mueller‐Wolf, Maya, additional, Pahernik, Sascha, additional, and Chin, Joseph L., additional

Published
2020
Full Text
View/download PDF

39. Histologic validation of auto-contoured dominant intraprostatic lesions on [18F] DCFPyL PSMA-PET imaging

Author

Alfano, Ryan, primary, Bauman, Glenn S., additional, Liu, Wei, additional, Thiessen, Jonathan D., additional, Rachinsky, Irina, additional, Pavlosky, William, additional, Butler, John, additional, Gaed, Mena, additional, Moussa, Madeleine, additional, Gomez, Jose A., additional, Chin, Joseph L., additional, Pautler, Stephen, additional, and Ward, Aaron D., additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results